Understanding how that resistance develops is critical
Lilly said in December that in a Phase 3 clinical trial, patients taking the highest dose of the experimental injection lost nearly 29% of their body weight on average after about 16 months more than has been seen with any GLP-1 drug currently on the market
Regarding thyroid effects: rodent studies with related GLP-1 receptor agonists have shown C-cell changes, but no causal link to thyroid tumours in humans has been established in UK or EU regulatory assessments
No, over-the-counter supplements cannot legally contain actual GLP-1 receptor agonists and lack the clinical evidence, standardization, and FDA oversight of prescription medications like semaglutide or tirzepatide
Do not double up to compensate
And then I would also ask about their history of how quickly they lost the weight, what dosage they are taking, and what's their diet like? After verifying the above formation, Park says she would suggest patients explore a hair-loss medication
